JP Morgan Call 165 ABT 20.06.2025/ DE000JK39U99 /
5/17/2024 8:40:39 AM | Chg.0.000 | Bid10:00:43 PM | Ask10:00:43 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.015EUR | 0.00% | - Bid Size: - |
- Ask Size: - |
Abbott Laboratories | 165.00 USD | 6/20/2025 | Call |
GlobeNewswire
5/9
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
3/25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
3/15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
11/14/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
10/19/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
10/2/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors